Helixgate

Helixgate

Uncategorized

Opinion: Check-in and intake at the doctor’s office are perfect for AI

I was the only person seated in the waiting room of an internal medicine specialty clinic for blood pressure issues. The day before the appointment I had completed the online registration, including demographics, past medical history, medications, allergies, etc. 

Upon arrival I was directed, as I am at the airport, to check in at a kiosk. However, instead of a person nearby to assist me to complete the process like at the airport, I then needed to go to the front desk, where the receptionist confirmed, again, the correct spelling of my name, my date of birth, insurance information, and queried about recent international travel. I was advised to sit in an adjacent room and wait.

Read the rest…

Read More

Published

on

I was the only person seated in the waiting room of an internal medicine specialty clinic for blood pressure issues. The day before the appointment I had completed the online registration, including demographics, past medical history, medications, allergies, etc. 

Upon arrival I was directed, as I am at the airport, to check in at a kiosk. However, instead of a person nearby to assist me to complete the process like at the airport, I then needed to go to the front desk, where the receptionist confirmed, again, the correct spelling of my name, my date of birth, insurance information, and queried about recent international travel. I was advised to sit in an adjacent room and wait.

Read the rest…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Published

on

After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.​ ​Read More

Continue Reading

Uncategorized

Chile offers new data on food warning label efficacy

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Published

on

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Continue Reading

Uncategorized

Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win

Published

on

The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.

Continue Reading
Advertisement

Trending